Overview

High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment

Status:
Terminated
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the toxicity and the effectiveness of high dose chemotherapy with HPC transplant Multiple Sclerosis that has failed at least two lines of therapy
Phase:
Phase 2
Details
Lead Sponsor:
Seah Lim M.D.
Treatments:
Alemtuzumab
Cyclophosphamide
Fludarabine
Fludarabine phosphate